Drug pricing roundup

In a continuing effort to keep you up-to-date on the current state of drug costs, we've rounded up a list of recent developments that are in the news this month, including a new study with good news about some generic drug costs during 2015, significant price increases for some commonly-prescribed medications, and the current backlog of generic drug applications at the FDA.

Study says 30 of top 50 generic drugs saw lower prices in 2015
According to the Washington Post, an analysis by GoodRx found that 30 of the 50 most popular generic drugs were actually less expensive by the end of 2015 than at the beginning of the year. These drugs cover nearly every common condition, from allergies to heart conditions to mental disorders.

Significant price increases for clobetasol and permethrin
Insurers continue to encourage patients to choose generic drugs because they are generally less expensive than brand-name equivalents. However, prices for some generics are rising at record rates this month, including permethrin and clobetasol propionate:

Trade name

Price increase

Permethrin 5% 60 GM

50.00%

Clobetasol propionate 0.05% 15 GM

844.66%

Clobetasol propionate 0.05% 30 GM

910.66%

Clobetasol propionate 0.05% 60 GM

693.21%

Considerable backlog of unapproved generic drugs
STAT recently reported that some prescription drug prices may be elevated due to a backlog of 4,300 generic drug applications currently awaiting Food and Drug Administration (FDA) approval. While pharmaceutical companies have threatened to abandon producing generic drugs because of the delay, the FDA "blames drug makers for sloppy and incomplete applications that slow the process."

Print